ATP Inhibits the Transcription Factor STAT5b

被引:6
|
作者
Berg, Angela [1 ]
Sperl, Bianca [2 ]
Berg, Thorsten [1 ]
机构
[1] Univ Leipzig, Inst Organ Chem, Johannisallee 29, D-04103 Leipzig, Germany
[2] Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany
关键词
bioactive compounds; inhibitors; nucleotides; protein-protein interactions; SH2; domain; SIGNAL TRANSDUCER; SELECTIVE INHIBITORS; DISCOVERY; ACTIVATOR; CANCER; MODULATORS; DOMAINS; TARGETS; POTENT; ASSAY;
D O I
10.1002/cbic.201900173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although naturally occurring low-molecular-weight compounds have many known roles within the cell, these do not usually involve the direct inhibition of protein-protein interactions. Based on the results of high-throughput screening of a library of bioactive compounds and neurotransmitters, we report here that the four nucleoside triphosphates ATP, GTP, CTP and UTP inhibit the SH2 domain of the tumor-related transcription factor STAT5b. ATP and GTP are the most active nucleoside triphosphates and show specificity for STAT5b over STAT5a, STAT3, STAT6 and the p53-binding protein HDM2. As the inhibition constant of ATP against STAT5b is significantly lower than published values for the intracellular ATP concentration, our data suggest that ATP might inhibit the protein-protein interactions of STAT5b in living cells.
引用
收藏
页码:2227 / 2231
页数:5
相关论文
共 50 条
  • [1] Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
    Elumalai, Nagarajan
    Berg, Angela
    Natarajan, Kalaiselvi
    Scharow, Andrej
    Berg, Thorsten
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (16) : 4758 - 4763
  • [2] Stat5b inhibits NFκB-mediated signaling
    Luo, GY
    Yu-Lee, LY
    MOLECULAR ENDOCRINOLOGY, 2000, 14 (01) : 114 - 123
  • [3] Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
    Hennighausen, Lothar
    Robinson, Gertraud W.
    GENES & DEVELOPMENT, 2008, 22 (06) : 711 - 721
  • [4] STAT5B in RICD
    Laurie A Dempsey
    Nature Immunology, 2018, 19 : 1 - 1
  • [5] STAT5b deficiency: Lessons from STAT5b gene mutations
    Hwa, Vivian
    Nadeau, Kari
    Wit, Jan M.
    Rosenfeld, Ron G.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 25 (01) : 61 - 75
  • [6] STAT5B in RICD
    Dempsey, Laurie A.
    NATURE IMMUNOLOGY, 2018, 19 (01) : 1 - 1
  • [7] Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
    Elumalai, Nagarajan
    Berg, Angela
    Rubner, Stefan
    Blechschmidt, Linda
    Song, Chen
    Natarajan, Kalaiselvi
    Matysik, Joerg
    Berg, Thorsten
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer
    Witkiewicz, A.
    Ryder, A.
    Neilson, L. M.
    Utama, F. E.
    Tran, T. H.
    Hyslop, T.
    Rui, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Identification of hTid1 as a Molecular Partner and a Negative Regulator of the Transcription Factor Stat5B
    Nyga, Remy
    Dhennin-Duthille, Isabelle
    Yahiaoui, Saliha
    Munger, Karl
    Regnier, Aline
    Gouilleux-Gruart, Valerie
    Lassoued, Kaiss
    Gouilleux, Fabrice
    BLOOD, 2008, 112 (11) : 1313 - 1313
  • [10] Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
    Nagarajan Elumalai
    Angela Berg
    Stefan Rubner
    Linda Blechschmidt
    Chen Song
    Kalaiselvi Natarajan
    Jörg Matysik
    Thorsten Berg
    Scientific Reports, 7